What does KOEDA develop?

They develop 'KOEDA™', an organ-anchoring device for endoscopic treatment created by a gastroenterologist.

What is the purpose of this investment?

To support the social implementation of KOEDA's innovative technology and bring breakthroughs to treatments for conditions like acute cholecystitis.

What are the characteristics of MUCAP's life science investment?

They target a wide range of fields including drug discovery and medical devices, offering long-term investment up to 12 years and support via the MUFG network.

AI News NQ Analysis

Mitsubishi UFJ Capital Invests in KOEDA, a Startup Developing Next-Generation Anchors for Digestive Disease Treatment

NQ Score 50/100

AI Summary (NQ-processed)

Mitsubishi UFJ Capital has invested in KOEDA, a startup developing organ-anchoring devices for endoscopic treatment.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What does KOEDA develop?: A: They develop 'KOEDA™', an organ-anchoring device for endoscopic treatment created by a gastroenterologist.
Q: What is the purpose of this investment?: A: To support the social implementation of KOEDA's innovative technology and bring breakthroughs to treatments for conditions like acute cholecystitis.
Q: What are the characteristics of MUCAP's life science investment?: A: They target a wide range of fields including drug discovery and medical devices, offering long-term investment up to 12 years and support via the MUFG network.